|Bid||7.31 x 900|
|Ask||29.23 x 800|
|Day's Range||17.97 - 18.67|
|52 Week Range||17.28 - 31.00|
|Beta (5Y Monthly)||0.52|
|PE Ratio (TTM)||15.48|
|Earnings Date||Feb 01, 2022 - Feb 07, 2022|
|Forward Dividend & Yield||0.48 (2.64%)|
|Ex-Dividend Date||May 31, 2022|
|1y Target Est||21.00|
By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) released 2021 operational and financial results in a press release on May 12, 2022, subsequently filing its 10-Q with the SEC and hosting a conference call with investors. Highlights for the first quarter and to-date include: ➢ Exclusive animal health license agreement with Phibro -
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Phibro Animal Health...
In Q3, Phirbo (PAHC) reports growth in the Animal Health business on higher sales of processing aids, which are used to improve production efficiency in the ethanol fermentation industry.